Follow-up Survey of Patients Who Were Treated for Medulloblastoma or Primitive Neuroectodermal Tumors of the Central Nervous in Norway

Brain Tumor Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02851355
• Other study ID #: 2015/2362
• Status: Completed
• Start date: September 2016
• Est. completion date: August 2018

Study information

• Verified date: March 2019
• Source: Oslo University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Clinical follow-up survey of the Norwegian material of paediatric patients who received therapy for medulloblastoma and CNS-PNET from 1974 - 2013 with a focus on quality of life, education, work, family and children, delayed effects of tumour disease and treatment, endocrine evaluation, existence of auditory neuropathy, and neuropsychological testing.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2
• Est. completion date: August 2018
• Est. primary completion date: September 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 5 Years to 51 Years

Eligibility

Inclusion Criteria:

• Whose who has been treated for medulloblastoma og CNS-PNET between 1974 and 2013

Exclusion Criteria:

• Other brain tumours

Related Conditions & MeSH terms

• Brain Tumor
• Neuroectodermal Tumors
• Neuroectodermal Tumors, Primitive

Locations

Country	Name	City	State
Norway	Einar Stensvold	Oslo

Sponsors (1)

Lead Sponsor	Collaborator
Oslo University Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	SF 36 for those older than 18 years	Questionnaire	1 year
Primary	PedsQL for those younger than 18 years	Questionnaire	1 year